利用偶联嗜水气单胞菌外膜蛋白的磷酸钙纳米颗粒开发尼罗罗非鱼口服疫苗
本研究以偶联嗜水气单胞菌外膜蛋白(OMP)的磷酸钙(CaP)纳米颗粒(CaP-OMP)作为新型口服疫苗递送系统,在尼罗罗非鱼中评估免疫应答与保护效果。结果显示,CaP-OMP 疫苗组特异性 IgM 应答和调理吞噬杀伤活性(OPKA)改善,关键免疫基因表达较 OMP 疫苗组显著上调;攻毒后 CaP-OMP 疫苗组相对存活率(RPS)为 85.7%,死亡率显著低于对照组。
要点
- CaP-OMP 口服疫苗可改善罗非鱼对嗜水气单胞菌的清除。
- CaP-OMP 组免疫基因表达较 OMP 组显著上调。
- 攻毒后 CaP-OMP 组 RPS 为 85.7%,死亡率显著低于对照。
核心结论
- 偶联嗜水气单胞菌 OMP 的 CaP 纳米颗粒作为口服疫苗平台,在罗非鱼中诱导增强的免疫应答并提供保护。
研究设计与样本
- 研究在尼罗罗非鱼中评估 CaP-OMP 口服疫苗,比较 CaP-OMP 疫苗组与 OMP 疫苗组及对照组的免疫应答与攻毒保护。
主要发现
- 特异性 IgM 应答和 OPKA 显示 CaP-OMP 疫苗接种鱼中嗜水气单胞菌清除改善。
- qPCR 显示 CaP-OMP 疫苗组关键免疫基因表达较 OMP 疫苗组显著上调。
- 攻毒后 CaP-OMP 疫苗组 RPS 为 85.7%,死亡率显著低于对照组。
关键数值与推荐
- CaP-OMP 疫苗组攻毒后 RPS 为 85.7%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The development of an effective vaccine for Oreochromis niloticus (Tilapia) against Aeromonas hydrophila, a major pathogen in aquaculture, is crucial for enhancing disease resistance and sustainability in fish farming. This study investigates the use of calcium phosphate (CaP) nanoparticles conjugated with the outer membrane protein (OMP) of A. hydrophila as a novel vaccine delivery system, referred to as CaP-OMP. Specific IgM response and Opsonophagocytic killing activity (OPKA) demonstrated improved Aeromonas clearance in vaccinated fish. Furthermore, immune gene expression analysis was performed using quantitative PCR (qPCR) to monitor the expression levels of key immune genes. The results showed a significant upregulation of these immune markers in the CaP-OMP vaccinated groups compared to that of OMP vaccinated groups, suggesting enhanced activation of both the innate and adaptive immune responses. The protective efficacy of the vaccine was demonstrated by a relative percentage survival (RPS) of 85.7 %, indicating significantly lower mortality in the CaP-OMP vaccinated group compared to controls following a challenge study with virulent A. hydrophila. Overall, This oral vaccine approach offers a non-invasive alternative for fish immunization and underscores the potential of calcium phosphate nanoparticles conjugated with outer membrane proteins as a promising vaccine platform for aquaculture. The enhanced immune response, combined with targeted antigen delivery, positions this strategy as a viable tool for controlling A. hydrophila infections in Tilapia, contributing to improved disease management in aquaculture.
引用
- Abhiram A, Krishnan R, Ahalya AK, et al. Development of oral vaccine using calcium phosphate nanoparticles conjugated with outer membrane protein of Aeromonas hydrophila in Oreochromis niloticus (Tilapia). Vaccine. 2025. PMID: 40683137. doi:10.1016/j.vaccine.2025.127508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。